Ledger.Open graph →
SEC Form D · filed July 14, 2021

Spero Therapeutics, Inc

Offering
$40.0M
Sold
$40.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (35)

Tamara C. Joseph · Cambridge, MAExecLex Ferenda Litigation Funding LLC · Rye Brook, NYDirectorJean-Francois Formela · Broomfield, CODirectorPatrick E. Vink · Cambridge, MADirectorCristina E. Larkin · Cambridge, MAExecJ. A. Antonelli · Provo, UTDirectorTimothy C. Keutzer · Cambridge, MAExecScott C. Jackson · Cambridge, MADirectorMatthew Hobbs · Raleigh, NCDirectorSatyavrat E. Shukla · Cambridge, MAExecVivekanand Arza · San Jose, CAExecInderpal M. Singh · New York, NYDirectorJohn Wires · Shawnee, KSExecJohn C. Pottage, Jr · Cambridge, MADirectorDaniel R. Karlin · DALLAS, TXDirectorFrank E. Thomas · Cambridge, MADirectorDavid E. Melnick · Cambridge, MAExecCristina E. Larkin · Cambridge, MAExecJohn C. Pottage, Jr · Cambridge, MADirectorDaniel Vitt · New York, NYExecAngus Burt · Edinburgh, United KingdomDirectorMichael Burt · Edinburgh, United KingdomExecAndreas Muehler · New York, NYDirectorJean-Francois Formela · Cambridge, MADirectorDeborah Jones · Raleigh, NCExecMilind Deshpande · Cambridge, MADirectorKevin D. Costello · Portland, MEExec · DirectorLex Ferenda Litigation Funding GP LLC · Rye Brook, NYDirectorCynthia C. Smith · Cambridge, MADirectorAnkit Mahadevia · Cambridge, MAExec · DirectorBarry D. Mower · Provo, UTDirectorKevin S. Lavelle · Dallas, TXDirectorGlenn M. Whaley · New York, NYExec · DirectorDavid E. Melnick · Cambridge, MAExecRachel Kern · DALLAS, TXExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗